Viral–Host Interactions Compromise Immunotherapy with a Conserved Elements DNA Vaccine in SIV-Infected Rhesus Macaques
Viruses · 16.11.2026 · 18 (11) · 1271
DOI: 10.3390/v18111271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 16.11.2026. Verfasst von Paul V. Munson und 14 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, Intramural Research Program of the National Institutes of Health.
Abstract (Originalsprache)
A DNA vaccine expressing conserved elements (CEs) of the SIV capsid (p27Gag) was designed to induce broad immune responses that can target diverse viral variants, limit immune escape and control viral rebound in the absence of antiretroviral therapy (ART). SIV-infected rhesus macaques receiving ART were primed with multiple doses of this vaccine co-formulated with a second plasmid expressing the genetic adjuvant, E. coli heat-labile enterotoxin (LT), via gene gun. During ART, virological suppression was highly variable across animals, with most macaques maintaining detectable viremia throughout the vaccination period. Following a boost consisting of a co-delivery of the adjuvanted CE DNA vaccine with a full-length (FL) SIV p57gag DNA vaccine, CE-primed macaques developed significantly higher CE-specific cellular and humoral immune responses than macaques immunized at each dose only with the full-length (FL) SIV p57gag DNA vaccine or mock-vaccinated controls. However, CE-specific responses were lower in macaques that had higher frequencies of myeloid-derived suppressor cells (MDSCs) and T cells expressing exhaustion markers. Upon ART interruption, all macaques exhibited a wide range in viral rebound and overall, there were no differences in mean viral loads or the time to viral rebound between the vaccinated and control groups. Notably, post-ART, the T cell repertoire shifted from CEs toward more variable sequences that were induced by the initial viral infection. These results suggest that ongoing viral replication during incomplete ART suppression, pre-existing virus-induced immune responses and persistent immune dysfunction can interfere with the immunogenicity and efficacy of a therapeutic vaccine designed to induce responses against conserved viral antigens.
Förderung
- National Institutes of Health
- Intramural Research Program of the National Institutes of Health
Zitieren
APA
Munson, P. V., Tunggal, H. C., Dross, S. E., O’Connor, M. A., Rosen, A., Lewis, T. B., Liu, Y., Bratt, D., Hajari, N., Fuller, J. T., Hu, X., Pavlakis, G. N., Felber, B. K., Mullins, J. I., & Fuller, D. H. (2026). Viral–Host Interactions Compromise Immunotherapy with a Conserved Elements DNA Vaccine in SIV-Infected Rhesus Macaques. Viruses, 18(11), 1271. https://doi.org/10.3390/v18111271
Vancouver
Munson PV, Tunggal HC, Dross SE, O’Connor MA, Rosen A, Lewis TB, et al. Viral–Host Interactions Compromise Immunotherapy with a Conserved Elements DNA Vaccine in SIV-Infected Rhesus Macaques. Viruses. 2026;18(11):1271. doi:10.3390/v18111271
BibTeX
@article{Munson2026,
author = {Munson, Paul V. and Tunggal, Hillary C. and Dross, Sandra E. and O’Connor, Megan A. and Rosen, Aliza and Lewis, Thomas B. and Liu, Yi and Bratt, Debra and Hajari, Nika and Fuller, James T. and Hu, Xintao and Pavlakis, George N. and Felber, Barbara K. and Mullins, James I. and Fuller, Deborah Heydenburg},
title = {Viral–Host Interactions Compromise Immunotherapy with a Conserved Elements DNA Vaccine in SIV-Infected Rhesus Macaques},
journal = {Viruses},
year = {2026},
volume = {18},
number = {11},
pages = {1271},
doi = {10.3390/v18111271}
}
EUVIMED